Lipid disorders panel
p.Val827Ile · Familial hypercholesterolaemia
Current evidence agrees with the interpretation on record.
2022 · On file
Uncertain significance
Reported 4 Jul 2022
Today · ClinVar
Uncertain significance
ClinVar last evaluated 22 Jun 2021 · Reviewed by expert panel
The changed variant and every historical record that carries it. Select a record to see its detail.
Variant
LDLR
c.2479G>A
VUSVUS
VP-10913
Reviewed45-54 · Lipid Clinic
Current evidence for LDLR c.2479G>A agrees with the uncertain significance interpretation issued in 2022. The classification was last evaluated on 22 Jun 2021 and carries 39 submissions.
Composed from the structured fields of the records cited on this page. Requires clinical verification before it informs any decision.
Each source is shown as it reports itself. VariantPulse does not merge them into a single verdict.
| Source | Classification | Review level | Last updated | Strength | |
|---|---|---|---|---|---|
| ClinVar39 submissions on record. | Uncertain significance | Reviewed by expert panel | 22 Jun 2021 | Strong3 of 4 review criteria met | VCV000036462 |
| Population frequencyHighest reported allele frequency carried on the source record. | 0.00077 | NHLBI Exome Sequencing Project (ESP) Exome Variant Server | 22 Jun 2021 | Reference observation | |
| LiteraturePublications linked to this variant record. | 8 indexed publications | PubMed index | Latest 2022 | Supporting context | |
| Regional Evidence IndexModelled regional aggregation maintained inside this workspace | No regional record | Not held | - | - | |
| This institutionThe interpretation issued to the patient at the time of testing. | Uncertain significance | Internal report | 4 Jul 2022 | On record |
Cited publications
LDLR c.2479G>A. The DNA is unchanged. The evidence around it is not.
The same records as a list, for scanning and screen readers.
No action required. Current evidence agrees with the interpretation on record.
Decision support only. Final interpretation remains with the qualified clinical team.